SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-059470
Filing Date
2023-11-06
Accepted
2023-11-06 16:39:52
Documents
96
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20230930.htm   iXBRL 10-Q 3012072
2 EX-31.1 axsm-ex31_1.htm EX-31.1 16118
3 EX-31.2 axsm-ex31_2.htm EX-31.2 15959
4 EX-32.1 axsm-ex32_1.htm EX-32.1 7349
5 EX-32.2 axsm-ex32_2.htm EX-32.2 7327
  Complete submission text file 0000950170-23-059470.txt   11841306

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20230930_lab.xml EX-101.LAB 618269
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axsm-20230930_cal.xml EX-101.CAL 60559
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20230930.xsd EX-101.SCH 82963
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axsm-20230930_def.xml EX-101.DEF 272252
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20230930_pre.xml EX-101.PRE 474322
90 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20230930_htm.xml XML 2243097
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 231380473
SIC: 2834 Pharmaceutical Preparations